SCHEMBL22340201

SCHEMBL22340201

CCOC(=O)[C@H]1C[C@H](Oc2cc(N)cc(OC)c2)C1

nearest known ligand 0.41

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
ALDH1A1 P00352 7/20 0.41
KDM4E B2RXH2 2/20 0.41
MAPT P10636 1/20 0.41
POLB P06746 2/20 0.40
TDP1 Q9NUW8 1/20 0.40
KMT2A Q03164 4/20 0.40
NPC1 O15118 2/20 0.39
RAB9A P51151 2/20 0.39
SMN1; SMN2 Q16637 2/20 0.38
GAA P10253 1/20 0.38
TSHR P16473 2/20 0.38
MAPK1 P28482 1/20 0.38
LGMN Q99538 1/20 0.38
MEN1 O00255 2/20 0.37
HSD11B1 P28845 1/20 0.37
CYP3A4 P08684 1/20 0.37
HPGD P15428 1/20 0.37
P2RX3 P56373 1/20 0.37
CA12 O43570 1/20 0.36
CA1 P00915 1/20 0.36

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL29775196 1.00 ALDH1A1 (0.41) ALDH1A1KDM4EMAPTPOLBTDP1
SCHEMBL22340149 1.00 ALDH1A1 (0.41) ALDH1A1KDM4EMAPTPOLBTDP1
SCHEMBL28345180 1.00 ALDH1A1 (0.41) ALDH1A1KDM4EMAPTPOLBTDP1
SCHEMBL29775198 0.84 MAPT (0.45) ALDH1A1KDM4EMAPTPOLBTDP1
SCHEMBL26599496 0.84 MAPT (0.45) ALDH1A1KDM4EMAPTPOLBTDP1
SCHEMBL28345587 0.84 MAPT (0.45) ALDH1A1KDM4EMAPTPOLBTDP1
SCHEMBL26599412 0.84 MAPT (0.45) ALDH1A1KDM4EMAPTPOLBTDP1
SCHEMBL22340036 0.83 SLC6A2 (0.35) ALDH1A1KDM4EMAPTKMT2ANPC1
SCHEMBL8707251 0.83 GAA (0.49) ALDH1A1KDM4EMAPTPOLBTDP1
SCHEMBL8707255 0.83 GAA (0.49) ALDH1A1KDM4EMAPTPOLBTDP1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-11795149-B2 Substituted indoline derivatives as dengue viral replication inhibitors Janssen Pharmaceuticals, Inc. (US) 2023-10-24 US disclosed
US-11795149-B2 Substituted indoline derivatives as dengue viral replication inhibitors Janssen Pharmaceuticals, Inc. (US) 2023-10-24 US disclosed
US-20200255376-A1 SUBSTITUTED INDOLINE DERIVATIVES AS DENGUE VIRAL REPLICATION INHIBITORS Janssen Pharmaceuticals, Inc. (BE) 2020-08-13 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-11795149-B2 Substituted indoline derivatives as dengue viral replication inhibitors IDO1, INMT, IRF3 ALDH1A1 3144/4885KDM4E 1020/4885MAPT 1807/4885
US-20200255376-A1 SUBSTITUTED INDOLINE DERIVATIVES AS DENGUE VIRAL REPLICATION INHIBITORS IDO1, INMT, IRF3 ALDH1A1 3144/4885KDM4E 1020/4885MAPT 1807/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.